Shares Of Applied DNA Sciences, Inc. (APDN) Recently Pulled Back, Is It Ready To Climb?

Applied DNA Sciences, Inc. (APDN) has seen some recent movement in the stock market and its common shares were last quoted at $9.25 yesterday.

Applied DNA Sciences, Inc. (APDN) has seen some recent movement in the stock market and its common shares were last quoted at $9.25 yesterday. Investors are starting to take notice of APDN as the common shares traded as high as $9.99 and as low as $9.17 in the prior market trading session.

Applied DNA Sciences, Inc. (APDN) average trading volume is 2.09M. However, in the prior market trading session Applied DNA Sciences, Inc. (APDN) exchanged 396,964 shares. The First support level on APDN is $7.46 and the First resistance level on APDN is $15.21. APDN fifty day moving average is $8.42 and APDN two hundred day moving average is $6.39.

Applied DNA Sciences, Inc. (APDN) current performance has been specified by the recent movement in APDN common shares. APDN has performed -0.32% over the past month, APDN has performed 38.47% over the past 90 days and APDN has shown -17.41% over the past 12 months. Applied DNA Sciences, Inc. (APDN) has a 1 year range of $2.52 to $19.69. Applied DNA Sciences, Inc. (APDN) is trading 267.06% from its 1 year low and -53.02% from its 1 year high. Applied DNA Sciences, Inc. (APDN) is indicating a 10.17% short float indicating the sum short in the float.

APDN has 4.68M shares outstanding and 3.95M shares in the float. Applied DNA Sciences, Inc. (APDN) at this time has a market cap of $45.05M and income of -8.60M. The EPS next quarter for APDN is -0.68 and forecasted EPS next year is 69.90%. The market cap of Applied DNA Sciences, Inc. (APDN) at $45.05M represents how many Investors own shares of APDN and is based off the last price ($9.25) of APDN and the sum of shares outstanding (4.68M) with Applied DNA Sciences, Inc. (APDN).

Applied DNA Sciences, Inc. (APDN) has aggregate cash (mrq) of 8.66M, aggregate cash per share (mrq) of 1.86, aggregate debt of APDN is at 1.49M and aggregate debt/equity (mrq) is 20.44. . Applied DNA Sciences, Inc. (APDN) running cash flow (ttm) is -8.21M, APDN leveraged free cash flow (ttm) is -4.84M.

APDN is trading 3.64% above (bullish) its SMA20, 2.10% above (bullish) its SMA50 and 49.35% above (bullish) its SMA200.

How Does Applied DNA Sciences Inc (APDN) Stock Compare to Others in Security & Protection …

Applied DNA Sciences Inc (APDN) stock is trading at $9.71 as of 1:39 PM on Friday, Jul 24, a drop of -$0.48, or -4.71% from the previous closing price of …

The 72 rating InvestorsObserver gives to Applied DNA Sciences Inc (APDN) stock puts it near the top of the Security & Protection Services industry. In addition to scoring higher than 97 percent of stocks in the Security & Protection Services industry, APDN’s 72 overall rating means the stock scores better than 72 percent of all stocks.

Overall Score - 72
APDN has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on APDN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 72 would rank higher than 72 percent of all stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What’s Happening With Applied DNA Sciences Inc Stock Today?

Applied DNA Sciences Inc (APDN) stock is trading at $9.71 as of 1:39 PM on Friday, Jul 24, a drop of -$0.48, or -4.71% from the previous closing price of $10.19. The stock has traded between $9.55 and $10.02 so far today. Volume today is low. So far 276,317 shares have traded compared to average volume of 1,536,007 shares.

To see InvestorsObserver‘s Sentiment Score for Applied DNA Sciences Inc click here.

Applied DNA Sciences Inc. (NASDAQ: APDN) Loses -48.25% From High. Why That Could Change?

With over 0.6 million Applied DNA Sciences Inc. (APDN) shares trading Wednesday and a closing price of $10.19 on the day, the dollar volume was …

Dillon Hill Capital LLC recently announced the acquisition of new stake in Applied DNA Sciences Inc. (NASDAQ:APDN). This fresh investment now brings its stake to 3.96% valued currently at $1.49 million. In addition, The Vanguard Group, Inc. raised its holdings by 7406.0 to 0.1 million shares. And BlackRock Fund Advisors has lifted its position by 0.00% or 1.0 shares – to 72512.0 shares.

With over 0.6 million Applied DNA Sciences Inc. (APDN) shares trading Wednesday and a closing price of $10.19 on the day, the dollar volume was approximately $6.16 million. The shares have shown a positive weekly performance of 35.24% and its price on 07/22/20 lost nearly -6.17%. Currently, there are 4.68M common shares owned by the public and among those 3.95M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 2 analysts who have offered their price forecasts for APDN have a consensus price objective of $21.50. The analysts have set the share’s price value over the next 12 months at a high of $22.00 and a low of $21.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Applied DNA Sciences Inc. stock is 2.00 for the next 12 months. But an upside of 53.68% will see the stock hit the forecast high price target while mean target price for the stock is $21.50.

Insiders at the company have transacted a total of 23 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 4,806,995 shares. Insider sales of the common stock occurred on 4 occasions, with total insider shares sold totaling 205,774 shares.

The top 3 mutual fund holders in Applied DNA Sciences Inc. are Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu. Vanguard Total Stock Market Index owns 88084.0 shares of the company’s stock, all valued at over $0.71 million. Fidelity Extended Market Index Fu now owns shares totaling to 0.44% of the shares outstanding.

Shares of Applied DNA Sciences Inc. (NASDAQ: APDN) opened at $10.90, up $0.04 from a prior closing price of $10.86. However, the script later closed the day at $10.19, down -6.17%. The company’s stock has a 5-day price change of 35.24% and 71.02% over the past three months. APDN shares are trading 159.19% year to date (YTD), with the 12-month market performance down to -4.27% lower. It has a 12-month low price of $2.52 and touched a high of $19.69 over the same period. Currently, 0.6 million shares have been traded, compared to an average intraday trading volume of 2.10 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 16.14%, 12.91%, and 64.55% respectively.

Institutional ownership of Applied DNA Sciences Inc. (NASDAQ: APDN) shares accounts for 14.30% of the company’s 4.68M shares outstanding. Mutual fund holders own 6.10%, while other institutional holders and individual stakeholders account for 8.57% and 3.54% respectively.

It has a market capitalization of $42.35M and a beta (3y monthly) value of 1.03. The earnings-per-share (ttm) stands at -$4.90. Price movements for the stock have been influenced by the stock’s volatility, which stands at 21.38% over the week and 11.90% over the month.

Analysts forecast that Applied DNA Sciences Inc. (APDN) will achieve an EPS of -$0.67 for the current quarter, -$0.27 for the next quarter and -$0.81 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.73 while analysts give the company a high EPS estimate of -$0.62. Comparatively, EPS for the current quarter was -$1.6 a year ago. Earnings per share for the fiscal year are expected to increase by 38.90%, and 69.90% over the next financial year.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 2 brokerage firm advisors rate Applied DNA Sciences Inc. (APDN) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 0 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the APDN, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on July 20, 2020, with the firm’s price target at $18-$22. H.C. Wainwright coverage for the Applied DNA Sciences Inc. (APDN) stock in a research note released on July 02, 2020 offered a Buy rating with a price target of $18. Maxim Group was of a view on November 14, 2016 that the stock is Buy, while Maxim Group gave the stock Buy rating on May 13, 2016, issuing a price target of $13- $9. Maxim Group on their part issued Buy rating on October 08, 2015.

Reviewing Applied DNA Sciences Inc. (APDN)’s and Check Point Software Technologies Ltd …

Both Applied DNA Sciences Inc. (NASDAQ:APDN) and Check Point Software Technologies Ltd. (NASDAQ:CHKP) are Security Software & Services …

Both Applied DNA Sciences Inc. (NASDAQ:APDN) and Check Point Software Technologies Ltd. (NASDAQ:CHKP) are Security Software & Services companies, competing one another. We will contrast their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation.

Valuation and Earnings

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences Inc.13.17N/A-0.400.00
Check Point Software Technologies Ltd.1178.78N/A5.1221.86

Table 1 shows top-line revenue, earnings per share and valuation of the two companies.

Profitability

Table 2 has Applied DNA Sciences Inc. and Check Point Software Technologies Ltd.’s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied DNA Sciences Inc.0.00%0%-217.3%
Check Point Software Technologies Ltd.0.00%21.7%14%

Risk and Volatility

Applied DNA Sciences Inc.’s 0.25 beta indicates that its volatility is 75.00% less volatile than that of Standard & Poor’s 500. Check Point Software Technologies Ltd.’s 22.00% less volatile than Standard & Poor’s 500 which is a result of the 0.78 beta.

Liquidity

The Current Ratio and Quick Ratio of Applied DNA Sciences Inc. are 1.2 and 1.1 respectively. Its competitor Check Point Software Technologies Ltd.’s Current Ratio is 1.6 and its Quick Ratio is 1.6. Check Point Software Technologies Ltd. can pay off short and long-term obligations better than Applied DNA Sciences Inc.

Analyst Ratings

In next table is delivered Applied DNA Sciences Inc. and Check Point Software Technologies Ltd.’s ratings and recommendations.

Sell RatingsHold RatingsBuy RatingsRating Score
Applied DNA Sciences Inc.0000.00
Check Point Software Technologies Ltd.0412.20

On the other hand, Check Point Software Technologies Ltd.’s potential upside is 15.66% and its consensus target price is $129.4.

Insider & Institutional Ownership

The shares of both Applied DNA Sciences Inc. and Check Point Software Technologies Ltd. are owned by institutional investors at 6% and 77.1% respectively. Insiders owned 23.39% of Applied DNA Sciences Inc. shares. Competitively, 24.8% are Check Point Software Technologies Ltd.’s share owned by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W)Performance (M)Performance (Q)Performance (HY)Performance (Y)Performance (YTD)
Applied DNA Sciences Inc.6.92%-41.53%-51.9%-34.46%-78.55%-25.45%
Check Point Software Technologies Ltd.-1.15%-4.95%-5.65%0.92%-1.4%9.06%

For the past year Applied DNA Sciences Inc. had bearish trend while Check Point Software Technologies Ltd. had bullish trend.

Summary

Check Point Software Technologies Ltd. beats Applied DNA Sciences Inc. on 9 of the 9 factors.

Check Point Software Technologies Ltd. provides hardware and software products and services for IT security worldwide. The company offers a portfolio of network security, endpoint security, data security, and management solutions. It provides security gateways to protect the networks and prevent the threats of enterprises, data centers, and small and large branch offices; security gateway appliances, including platforms for small business and small office locations, high end and high demanding data centers, and perimeter environments; and security management software, which offers security management through a single console that streamlines security operations and provides visibility into policy administration and threat analysis. The company also offers vSEC product line and advanced threat prevention technologies, which enables customers to build a secure infrastructure today and protect future deployments across private and public cloud solutions; and mobile security solutions that protects devices from threats on the device (OS), in apps, and in the network, as well as delivers a threat catch rate for iOS and Android. In addition, it provides threat protection solutions, such as SandBlast Agent and SandBlast Cloud, cloud and endpoint options, and ThreatCloud infrastructure solutions. Further, the company offers technical services, including technical customer support programs and plans; professional services in implementing, upgrading, and optimizing products comprising design planning and security implementation; and certification and educational training services. It sells its products and services to enterprises, service providers, small and medium sized businesses, and consumers through a network of channel partners, such as distributors, resellers, original equipment manufacturers, system integrators, and telcos and managed service providers. Check Point Software Technologies Ltd. was founded in 1993 and is headquartered in Tel Aviv, Israel.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Applied DNA Sciences, Inc. (APDN) Up 9.71%: Why This Stock Is Lively Today

Applied DNA Sciences, Inc. (NASDAQ:APDN) is among the top gainers of the stock market today, skyrocketing 9.71% or (0.03 points) to $0.35 from its …

Applied DNA Sciences, Inc. (NASDAQ:APDN) is among the top gainers of the stock market today, skyrocketing 9.71% or (0.03 points) to $0.35 from its previous close of $0.32. Does this growth mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 378438 contracts so far this session. APDN shares had a relatively better volume day versus average trading capacity of 366.05 thousand shares, but with a 32.14 million float and a 8.54% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for APDN stock indicates that the average analyst price target is $4 per share. This means the stock has a potential increase of 1042.86% from where the APDN share price has been trading recently which is between $0.307 and $0.3289. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $3.

The shorts are running away from Applied DNA Sciences, Inc. (APDN) stock. The latest set of short interest data was released on 30 August 2019, and the numbers show a drop in short interest in APDN shares. While short interest still represents only 2.24% of APDN’s float, the number of shares shorted have fallen by -131239. The number of shares shorted fell to 589082 shares, down from 720321 shares during the preceding fortnight. With average daily trading volumes at 222926 shares, days to cover increased to about 1.98388 days. The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Applied DNA Extends Textiles Business to Include Global Down and Feather Supply Chain in Partnership with Industry Leader Navarpluma” and dated September 05, 2019.

During the recent trading session for Applied DNA Sciences, Inc. (NASDAQ:APDN), the company witnessed their stock rise $0.05 over a week and surge $0.06 from the price 20 days ago. When compared to their established 52-week high of $1.84, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 09/25/18. The recent low of $0.25 stood for a -81.21% since 08/22/19, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 0.25 is also allocated to the stock. Since the beta is less than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.

Looking at the current readings for Applied DNA Sciences, Inc., the two-week RSI stands at 54.08. This figure suggests that APDN stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current APDN readings is similarly very revealing as it has a stochastic reading of 64.74% at this stage. This figure means that APDN share price today is being neutral.

Technical chart claims that Applied DNA Sciences, Inc. (APDN) would settle between $0.37/share to $0.39/share level. However, if the stock price goes below the $0.31 mark, then the market for Applied DNA Sciences, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $0.27 for its downside target. The stock is currently in the green zone of MACD, with the indicator reading 0.01. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.

Analysts at Maxim Group lifted target price for shares of APDN but were stick to Buy recommendation for the stock in their opinion released on November 14. The price target has been raised from $8 to $6. Maxim Group analysts again handed out a Buy recommendation to Applied DNA Sciences, Inc. (NASDAQ:APDN) stock but they lifted target price for the shares in a flash note issued to investors on May 13. The target price has been raised from $13 to $9. Analysts at Maxim Group are sticking to their Buy stance. However, on October 08, they lifted price target for these shares to $13 from $9.

APDN equity has an average rating of 3, with the figure leaning towards a bullish end. 1 analysts who tracked the company were contacted by Reuters. Amongst them, 1 rated the stock as a hold while the remaining 0 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 0 analysts rated Applied DNA Sciences, Inc. (NASDAQ:APDN) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.

Moving on, APDN stock price is currently trading at 0X forward 12-month Consensus EPS estimates, and its P/E ratio is NA while for the average stock in the same group, the multiple is NA. Applied DNA Sciences, Inc. current P/B ratio of NA means it is trading at a premium against its industry’s NA.